
Zydus Lifesciences hit a 52-week high, up 17% in a month, as four BSE 200 stocks reached new peaks. The next quarterly results will test the rally's sustainability.
Four BSE 200 stocks hit 52-week highs on Wednesday, led by Zydus Lifesciences. The pharmaceutical company touched Rs 1,119, its strongest level in a year, and closed at Rs 1,096.8. The stock has gained about 17% over the past month.
Three other stocks also reached new peaks. Their gains ranged from 4% to 5% in the same period. The broader Sensex edged up 64 points to 73,983 on the session.
Zydus's rally has outpaced the index by a wide margin. The stock now trades near its record high. The next quarterly results will test whether the momentum is backed by earnings growth.
For more on the broader market moves, see our stock market analysis.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.